Poised To Produce A/H1N1 Vaccine, Sanofi Pasteur Ramping Up Capacity In U.S., Developing Defense For Another Killer Virus
This article was originally published in PharmAsia News
Executive Summary
BEIJING - On standby to rapidly turn out a vaccine for A/H1N1 if the World Health Organization declares a continents-wide pandemic is emerging, scientists at Sanofi Pasteur are also working with the UN group to develop a defense for the tropical dengue virus, which has already killed far more people worldwide than the swine flu
You may also be interested in...
Chinese Government Expects Prepared H1N1 Vaccine By July, But MNCs Say Longer
HONG KONG - The number of cases of swine flu continues to mount across Southeast Asia and the world, but despite what the Chinese government suggests, an effective vaccine is still months away
Chinese Government Expects Prepared H1N1 Vaccine By July, But MNCs Say Longer
HONG KONG - The number of cases of swine flu continues to mount across Southeast Asia and the world, but despite what the Chinese government suggests, an effective vaccine is still months away
Swine Flu Vaccines Likely to Be Shielded From Tort Claims
Vaccine manufacturers are ready to begin producing swine flu vaccines once the government gives them the nod to go forward. As they do so, they may be free from one worry: the risk of being sued for vaccine-related injuries